Denali Therapeutics Inc (DNLI)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$23.00

Buy

$26.10

arrow-down$-0.62 (-2.53%)

Prices updated at 11 Dec 2024, 10:10 EST
| Prices minimum 15 mins delay
|
Prices in USD
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
NASDAQ
arrow-up1.77%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$24.69 - $23.85
$33.33 - $14.56
-
3,435.41m
-
-
11
2.61
1,087,917.13
1.12
138.39m
US24823R1059
-2.76
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.